Urinary Incontinence

Abstract

Although UI can be controlled relatively well with existing therapies, only about 50% of affected patients may actually seek care. There are a variety of therapeutic options available for the treatment of UI, although pharmacologic intervention is presently a relatively minor component of overall care; this suggests that effective drug therapy might play a more significant role in the future. The economic burden associated with the care of the incontinent patient is substantial, and in the US the direct medical cost of the disease was estimated at $25.5 billion in 1995. The disease also has a large impact on the individual UI patient, negatively affecting many parameters normally associated with a tolerable health-related quality of life.

Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years

“…The prevalence of OAB is estimated to be 16.6% among adults aged 40 years and older . While OAB is not inevitable, its prevalence increases with age . OAB is linked to the urodynamic observation of DO.…”

“…18 While OAB is not inevitable, its prevalence increases with age. 19,20 OAB is linked to the urodynamic observation of DO. DO is detected in about half of female patients with OAB.…”

Virtual patient case: study of a urinary incontinence therapy procedure in a woman

“…All of them have some shortcomings and advantages. None is universal or fully effective [4,5], which is why many of them have been developed. New therapeutic proposals come also into existence, with the implementation of methods, which take advantage of developments in molecular biology and robotics dedicated to enhancement of effectiveness of treatment and work of the doctor [6][7][8][9][10].…”

Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction

“…In addition to antimuscarinic treatments, other current treatments for UI include behavioral modification, such as bladder training, fluid manipulation, scheduled toileting, pelvic muscle exercises, and surgical interventions. Often, pharmacological treatment and behavioral modification are combined [11, 18, 19]. …”